Insulin Pumps (External) - Global Strategic Business Report 2014: Complicated Insulin Pump Software Makes Pump Use Difficult for the Aged

News provided by

Research and Markets

21 May, 2014, 12:39 GMT

DUBLIN, May 21, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/vzwl7f/insulin_pumps) has announced the addition of the "Insulin Pumps (External) - Global Strategic Business Report" report to their offering.

Continue Reading
Research and Markets Logo. (PRNewsFoto/PR NEWSWIRE EUROPE)
Research and Markets Logo. (PRNewsFoto/PR NEWSWIRE EUROPE)

http://photos.prnewswire.com/prnh/20130307/600769

This report analyzes the worldwide markets for Insulin Pumps (External) in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World.

Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.

The report profiles 13 companies including many key and niche players such as:

  • Animas Corp.
  • Debiotech S.A
  • F. Hoffmann-La Roche, Ltd.
  • Insulet Corp
  • Medtronic

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
  • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study

II. EXECUTIVE SUMMARY
1. INDUSTRY OVERVIEW

  • Insulin Pumps: A Prelude
  • The United States
  • The Largest Market
  • Europe
  • A Market with Vast Potential
  • Rising Incidence of Diabetes
  • The Driving Factor
  • Table 1: Worldwide Prevalence of Diabetes Mellitus by Region: 2013 & 2035 P (includes corresponding Graph/Chart)

2. COMPETITIVE ANALYSIS

  • Insulin Pumps Market
  • Set for Interesting Road Ahead
  • Comparison of Select Insulin Pumps by Manufacturer
  • Competition Heats Up in the Patch Pumps Market
  • Tough Ground for New Entrants

3. MARKET TRENDS AND ISSUES

  • The Rise of Smart Pumps
  • A Major Game Changer
  • Artificial Pancreas System (APS)
  • The Future of Diabetes Care
  • Type II Diabetes
  • A Market with Significant Potential
  • The Risk of Diabetes in Aging Populace Presents Opportunities for Insulin Pumps
  • Alarming Rise in Obesity
  • A Business Case for Diabetes Care
  • Diabetes in Developing Countries to Expand Opportunities
  • Innovative Features Spruce Up the Market for Insulin Pumps
  • Patch Pumps Gain Manufacturer Attention
  • ICR: A Key Factor to Success
  • Expiry of Warranty Provides New Opportunities to Insulin Pump Makers
  • Teenagers Outdo Adults in Controlling Diabetes
  • Customer Satisfaction: Crucial to Stay Competitive

4. CHALLENGES

  • Implantable Insulin Pumps
  • A Potential Threat to External Insulin Pumps
  • Insulin Pump Training
  • Not Receiving Adequate Attention
  • Complicated Insulin Pump Software Makes Pump Use Difficult for the Aged
  • Competition from Other Insulin Delivery Technologies Continues
  • Undiagnosed Diabetes
  • A Key Challenge
  • Lantus: A Threat to Insulin Pump Manufacturers

5. DIABETES - INCIDENCE AND PREVALENCE

  • A Demographic Analysis by Geographic Region
  • North America
  • United States
  • Canada
  • Mexico
  • Asia-Pacific
  • Southeast Asian Region
  • Western Pacific Region
  • South & Central America
  • Type-1 Diabetes
  • Type-2 Diabetes

6. DIABETES & INSULIN AN ABSTRACT

  • Diabetes
  • A Fatal Disease
  • Risk Factors for Diabetes
  • Types of Diabetes
  • Long Term Complications of Diabetes
  • Testing Sugar Levels: Easy and Accurate
  • Insulin
  • Pancreas: The Main Source of Insulin in Human Body
  • Types of Insulin
  • Types of Insulin & Onset of Action
  • Goal of Insulin Therapy
  • Insulin Delivery Systems

7. PRODUCT OVERVIEW

8. PRODUCT INNOVATIONS/INTRODUCTIONS

9. RECENT INDUSTRY ACTIVITY

10. FOCUS ON SELECT KEY PLAYERS

  • Animas Corp. (USA)
  • Debiotech S.A. (Switzerland)
  • F. Hoffmann-La Roche, Ltd. (Switzerland)
  • Insulet Corp. (USA)
  • Medtronic (USA)
  • Medtronic Diabetes (USA)
  • Sooil Development Co. Ltd. (Korea)
  • Tandem Diabetes Care Inc. (USA)
  • Valeritas Inc. (US)
  • Ypsomed Holding AG (Switzerland)

11. GLOBAL MARKET PERSPECTIVE

III. MARKET
1. THE UNITED STATES
2. CANADA
3. JAPAN
4. EUROPE
5. ASIA-PACIFIC
6. LATIN AMERICA
7. REST OF WORLD

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 13 (including Divisions/Subsidiaries 16)

  • The United States (10)
  • Europe (4)
  • Asia-Pacific (Excluding Japan) (2)

For more information visit http://www.researchandmarkets.com/research/vzwl7f/insulin_pumps

Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net